Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Squamous Cell Cancer × MEDI0457 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Oropharyngeal Neoplasms 1 Head and Neck Squamous Cell Cancer 1

Interventions

Cetuximab 2 Alpelisib 2 toripalimab 1 sintilimab 1 rocakinogene sifuplasmid 1 raltitrexed 1 cabozantinib 1 VGX-3100 1 Radiotherapy, Intensity-Modulated 1 Metformin 1 MEDI0457 1 Fluorouracil 1 Cisplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02163057 2021-01-22

Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma

Inovio Pharmaceuticals

Phase 1/2 Completed

22 enrolled 14 charts

Head and Neck Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡